Pharmabiz
 

RMS Babycell organises CME on 'regenerative medicine' in Pune

Our Bureau, MumbaiTuesday, December 8, 2009, 08:00 Hrs  [IST]

Babycell, a cord blood banking division of RMS has organized Continuous Medical Education (CME), a podium to create awareness about the Regenerative Medicines in Pune in Hotel IBIS, Viman Nagar. It has witnessed the presence of gynecologists and medical practitioners from Pune. Regenerative Medicine is an emerging field of interdisciplinary research with clinical implications focused on repair, replacement or regeneration of cells to salvage impaired organ function. Focusing on the various aspects and applications of stem cells and cord blood banking, CME has scheduled presentations by Dr Amita Phadnis on Applications of Stem Cells in Pediatrics, and Dr Dilip Walke on Medico – Legal Aspects of cord Blood Banking. Talking about the importance of stem cell in Paediatrics, Dr Amita Phadnis, director, Oyster & Pearl (O&P) Hospital said, “In the future, we are sure to witness a revolution in stem cell research and this sector would surely take great strides for the advancement of stem cell research technology and application.” Sharing the in depth insights on the legal aspects of Cord Blood Banking Dr Dilip Walke mentioned, “Cord blood banking is a once in a lifetime opportunity and all new parents should utilize cord blood banking if possible.” From biological insurance, repository services, autologous and allogenic transplants, assisted devices to system solutions the tremendous and potential of stem cell research can be envisioned by viewing it from three different perspectives – science, unmet medical needs and potential product and services range, said experts at the CME. Speaking on the occasion Satyen Sanghvi, chief scientific officer, RMS and chief mentor behind the CME said, “Regenerative Medicines is an emerging filed in India and through CME, Babycell is kick starting awareness drive about stem cell therapy and cord blood banking where experts from the industry can share their insights and the benefits to the Indian patients.” RMS is the leading company in India focused in the delivery of the most advanced cell therapy treatments. BabyCell is a family cord blood bank initiated in strategic partnership with Korean Technology partners, Sewon Cellontech, the first ever ISO 9001 certified umbilical cord blood bank in Korea.

 
[Close]